| Jason Blair Litten, MD | |
|
5323 Harry Hines Bouldevard, Dallas, TX 75390-9063 | |
| (214) 648-3896 | |
| (214) 456-6133 |
| Full Name | Jason Blair Litten |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 5323 Harry Hines Bouldevard, Dallas, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174745061 | NPI | - | NPPES |
| 8AL506 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | M7374 (Texas) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Jason Blair Litten, MD 5323 Harry Hines Bouldevard, Dallas, TX 75390-9063 Ph: (214) 648-3896 | Jason Blair Litten, MD 5323 Harry Hines Bouldevard, Dallas, TX 75390-9063 Ph: (214) 648-3896 |
News Archive
Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced that it has dosed the first patient in a Phase 2 trial evaluating AKB-9778, a Tie2 activator, alone and in combination with ranibizumab (Lucentis) for the treatment of diabetic macular edema (DME). AKB-9778 is a first-in-class inhibitor of human protein tyrosine phosphatase beta (HPTPβ) that activates the Tie2 pathway to promote vascular stability, preventing abnormal blood vessel growth and vascular leak.
MIT engineers have developed a new, highly efficient way to pair up cells so they can be fused together into a hybrid cell.
The Drug Enforcement Administration, as part of its efforts to control the abuse and misuse of controlled substances and chemicals used in producing some over-the-counter drugs, maintains databases of individuals registered to handle these substances.
Traditionally, babies in the Neonatal Intensive Care Unit (NICU) are temporarily identified by gender and last name, such as Babyboy Jackson or Babygirl Smith, but this naming configuration can result in wrong-patient errors for the fragile newborns.
› Verified 4 days ago
Dr. Jyothsna Gattineni, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3438 | |
Ruth Osei Fordjour, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 12221 Merit Dr, Suite 1500, Dallas, TX 75251 Phone: 214-957-4754 | |
Dr. Alecia Curlene Nero, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-4180 | |
Dr. Sravani Avula, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-730-5437 | |
Asif Zia Khattak, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3500 Gaston Ave, Dallas, TX 75246 Phone: 214-820-7604 | |
Sadia Malik, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5323 Harry Hines Boulevard, Dallas, TX 75390 Phone: 214-456-2533 Fax: 214-456-8130 | |
Sana Jamil Siddiqui, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5323 Harry Hines Boulevard, Dallas, TX 75390 Phone: 214-456-0488 Fax: 214-456-4486 |